Zobrazeno 1 - 10
of 244
pro vyhledávání: '"Prandini, S"'
Autor:
Breno M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Noris M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Rubis N; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Parvanova AI; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Martinetti D; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Gamba S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Liguori L; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Mele C; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Piras R; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Orisio S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Valoti E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Alberti M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Diadei O; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Bresin E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Rigoldi M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Prandini S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Gamba T; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Stucchi N; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Carrara F; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Daina E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Benigni A; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy., Remuzzi G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.
Publikováno v:
IScience [iScience] 2023 Aug 16; Vol. 26 (10), pp. 107629. Date of Electronic Publication: 2023 Aug 16 (Print Publication: 2023).
Publikováno v:
European Journal of Cancer Prevention, 2004 Dec 01. 13(6), 485-489.
Externí odkaz:
https://www.jstor.org/stable/45051452
Background: Microalbuminuria is an early sign of kidney disease in people with diabetes and indicates increased risk of cardiovascular disease. We tested whether a urinary proteomic risk classifier (CKD273) score was associated with development of mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::eeb27409505a02b950c484786fe72848
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077412
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077412
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruggenenti, P, Lauria, G, Iliev, IP, Fassi, A, Ilieva, AP, Rota, S, Chiurchiu, C, Barlovic, DP, Sghirlanzoni, A, Lombardi, R, Penza, P, CAVALETTI, GUIDO ANGELO, Piatti, ML, Frigeni, B, Filipponi, M, Rubis, N, Noris, G, Motterlini, N, Ene Iordache, B, Gaspari, F, Perna, A, Zaletel, J, Bossi, A, Dodesini, AR, TREVISAN, ROBERTO, Remuzzi, G, DEMAND Study Investigators, Parvanova, IA, Petrov, II, Yakymchuk, S, Arnoldi, F, Prandini, S, Kocijancic, A, Pongrac, D, Prezelj, J, Gala, T, Kersnik, M, Trevisan, G, Lepore, G, Mondo, E, Inversi, F, Mangili, R, Bruno, S, Brusegan, V, Lecchi, V, Belviso, A, Genovese, S, Pareyson, D, Camozzi, F, Cavaletti, G, Marzorati, L, MARMIROLI, PAOLA LORENA, Mattavelli, L, Tadini, S, Gherardi, G, Calini, W, Diadei, O, Rossoni, D, Villa, D, Carminati, S, Agus, E, Remuzzi, A, Giuliano, GA, Ganeva, M, Cannata, AN, Carrara, F, Cella, C, Centemeri, E, Ferrari, S, Petrò, C, Savoldelli, E, Stucchi, N, Boccardo, P, Perico, N, Peracchi, S, Gelmi, S, Mecca, G, Imbimbo, B, Alberici, M, Gardini, F, Lauria, G.
Publikováno v:
Hypertension. 58:776-783
To assess whether angiotensin-converting enzyme inhibitors and third-generation dihydropyridine calcium channel blockers ameliorate diabetic complications, we compared glomerular filtration rate (GFR; primary outcome), cardiovascular events, retinopa
Autor:
Ruggenenti P; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.; Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Cortinovis M; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Parvanova A; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Trillini M; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Iliev IP; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Bossi AC; Unit of Diabetology and Metabolic Diseases, Azienda Socio-Sanitaria Territoriale Bergamo Ovest, Treviglio-Caravaggio-Romano, Bergamo, Italy., Belviso A; Poliambulatorio extra-ospedaliero, Azienda Socio-Sanitaria Territoriale Bergamo Ovest, Brembate di Sopra, Bergamo, Italy., Aparicio MC; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Trevisan R; Unit of Diabetology and Endocrinology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Rota S; Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Perna A; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Peracchi T; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Rubis N; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Martinetti D; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Prandini S; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Gaspari F; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., Carrara F; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy., De Cosmo S; Unit of Internal Medicine, Research Hospital 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, Foggia, Italy., Tonolo G; SC Diabetologia Aziendale ASL 2 Olbia, San Giovanni di Dio Hospital, Olbia, Italy., Mangili R; Azienda Socio-Sanitaria Territoriale Bergamo Est, Seriate, Bergamo, Italy., Remuzzi G; Department of Renal Medicine, Clinical Research Center for Rare Diseases, 'Aldo e Cele Daccò': Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
Publikováno v:
PLoS medicine [PLoS Med] 2021 Jul 14; Vol. 18 (7), pp. e1003691. Date of Electronic Publication: 2021 Jul 14 (Print Publication: 2021).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.